Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity of Alberta

About this trial

CAPTURE ALS is a long-term data and biorepository platform that will facilitate future ALS research. CAPTURE ALS will provide the standardized systems and tools necessary to collect, store, and analyze vast amounts of multimodal information about ALS. These multimodal datasets and biosamples will be made available for use by researchers or industry across Canada and around the world in accordance with the CAPTURE ALS Data Sharing Policy to advance research on ALS.

Eligibility criteria

Qualifiers

Has ALS, classified as definite, probable, laboratory-supported probable, or possible ALS according to the revised El Escorial criteria or a related neurodegenerative disorder including ALS-FTD, PLS, PMA or asymptomatic individuals with a known ALS mutation (as previously confirmed during regular clinical care)

Be of the age of majority in their province of residence/treatment

Have the cognitive capacity to provide informed consent

Have proficiency in English or French in order to understand study instructions and respond to questionnaires

Disqualifiers

Be between the ages of 40-80 unless age matched to a patient (+/-3 years) who is already enrolled

Be the age of majority in their province of residence/treatment

Have the cognitive capacity to provide informed consent

Have proficiency in English of French to understand study instructions and respond to questionnaires

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

University of Alberta

Lead sponsor

McGill University

Collaborator

Laval University

Collaborator

University of Toronto

Collaborator

Simon Fraser University

Collaborator